Chieh‐Kai Chan

715 total citations
29 papers, 360 citations indexed

About

Chieh‐Kai Chan is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chieh‐Kai Chan has authored 29 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chieh‐Kai Chan's work include Hormonal Regulation and Hypertension (18 papers), Adrenal and Paraganglionic Tumors (13 papers) and Adrenal Hormones and Disorders (7 papers). Chieh‐Kai Chan is often cited by papers focused on Hormonal Regulation and Hypertension (18 papers), Adrenal and Paraganglionic Tumors (13 papers) and Adrenal Hormones and Disorders (7 papers). Chieh‐Kai Chan collaborates with scholars based in Taiwan, United States and Mexico. Chieh‐Kai Chan's co-authors include Vin‐Cent Wu, Yung‐Ming Chen, Kwan‐Dun Wu, Shih‐Chieh Chueh, Yen‐Hung Lin, Kuo‐How Huang, Wen‐Chih Chiang, Ping-Min Chen, Tun‐Jun Tsai and Hung‐Wei Liao and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Scientific Reports.

In The Last Decade

Chieh‐Kai Chan

27 papers receiving 360 citations

Peers

Chieh‐Kai Chan
Chieh‐Kai Chan
Citations per year, relative to Chieh‐Kai Chan Chieh‐Kai Chan (= 1×) peers Mitsuhito Koizumi

Countries citing papers authored by Chieh‐Kai Chan

Since Specialization
Citations

This map shows the geographic impact of Chieh‐Kai Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chieh‐Kai Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chieh‐Kai Chan more than expected).

Fields of papers citing papers by Chieh‐Kai Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chieh‐Kai Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chieh‐Kai Chan. The network helps show where Chieh‐Kai Chan may publish in the future.

Co-authorship network of co-authors of Chieh‐Kai Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Chieh‐Kai Chan. A scholar is included among the top collaborators of Chieh‐Kai Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chieh‐Kai Chan. Chieh‐Kai Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Vin‐Cent, Kang‐Yung Peng, Chiao-Yin Sun, et al.. (2025). C-terminal FGF-23 production coupling with aldosterone via FAM20C and predicting cardiovascular events in primary aldosteronism. JCI Insight. 10(4). 1 indexed citations
2.
Chan, Chieh‐Kai, Wei‐Shiung Yang, Yen‐Hung Lin, et al.. (2025). KCNJ5 Somatic Mutations Are Associated With Better Long-term Outcomes in Patients With Unilateral Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 110(9). e2918–e2928. 4 indexed citations
3.
Chen, Zheng‐Wei, Chieh‐Kai Chan, Chia-Hung Lin, et al.. (2024). Evaluations of secondary hypertension and laboratory data in the elderly population. Journal of the Formosan Medical Association. 124. S24–S31. 1 indexed citations
4.
Huang, Shun‐Chen, Chien‐Ting Pan, Kang‐Yung Peng, et al.. (2023). The predictors of long-term outcomes after targeted therapy for primary Aldosteronism. Journal of the Formosan Medical Association. 123. S135–S140. 1 indexed citations
5.
Pan, Chien‐Ting, et al.. (2023). Follow-up care and assessment of comorbidities and complications in patients with primary aldosteronism: The clinical practice guideline of the Taiwan Society of aldosteronism. Journal of the Formosan Medical Association. 123. S141–S152. 1 indexed citations
6.
Tseng, Chi‐Shin, Chieh‐Kai Chan, Hsiang‐Ying Lee, et al.. (2023). Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism. Journal of the Formosan Medical Association. 123. S125–S134. 8 indexed citations
7.
Wu, Vin‐Cent, Chieh‐Kai Chan, Shih‐Chieh Chueh, et al.. (2023). Markers of Kidney Tubular Function Deteriorate While Those of Kidney Tubule Health Improve in Primary Aldosteronism After Targeted Treatments. Journal of the American Heart Association. 12(4). e028146–e028146. 10 indexed citations
8.
Wu, Vin‐Cent, Kang‐Yung Peng, Chin‐Chen Chang, et al.. (2022). Circulating Plasma Concentrations of ACE2 in Primary Aldosteronism and Cardiovascular Outcomes. The Journal of Clinical Endocrinology & Metabolism. 107(12). 3242–3251. 1 indexed citations
9.
Chang, Che‐Mai, Kang‐Yung Peng, Chieh‐Kai Chan, et al.. (2022). Divergent Characteristics of T-Cell Receptor Repertoire Between Essential Hypertension and Aldosterone-Producing Adenoma. Frontiers in Immunology. 13. 853403–853403. 3 indexed citations
10.
Pan, Heng‐Chih, Yung‐Ming Chen, I‐Jung Tsai, et al.. (2021). Accelerated versus standard initiation of renal replacement therapy for critically ill patients with acute kidney injury: a systematic review and meta-analysis of RCT studies. Critical Care. 25(1). 5–5. 24 indexed citations
11.
Hsieh, Ju-Chun, Cheng‐Han Chao, Hui‐Teng Cheng, et al.. (2020). Correlation between breath ammonia and blood urea nitrogen levels in chronic kidney disease and dialysis patients. Journal of Breath Research. 14(3). 36002–36002. 48 indexed citations
12.
Chan, Chieh‐Kai, et al.. (2020). Renin-angiotensin-aldosterone system inhibition decreased contrast-associated acute kidney injury in chronic kidney disease patients. Journal of the Formosan Medical Association. 120(1). 641–650. 8 indexed citations
13.
Chan, Chieh‐Kai, Yu‐Shan Huang, Hung‐Wei Liao, et al.. (2020). Renin-Angiotensin-Aldosterone System Inhibitors and Risks of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Hypertension. 76(5). 1563–1571. 23 indexed citations
14.
Chan, Chieh‐Kai, Tai‐Shuan Lai, Tao‐Min Huang, et al.. (2020). Long-term outcomes following vehicle trauma related acute kidney injury requiring renal replacement therapy: a nationwide population study. Scientific Reports. 10(1). 20572–20572. 2 indexed citations
15.
Chan, Chieh‐Kai, Wei‐Shiung Yang, Yen‐Hung Lin, et al.. (2020). Arterial Stiffness Is Associated with Clinical Outcome and Cardiorenal Injury in Lateralized Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 105(11). e3950–e3960. 14 indexed citations
16.
Chan, Chieh‐Kai, Jung Hee Kim, Chin‐Chen Chang, et al.. (2019). Aldosterone level after saline infusion test could predict clinical outcome in primary aldosteronism after adrenalectomy. Surgery. 166(3). 362–368. 13 indexed citations
17.
Chan, Chieh‐Kai, Ya‐Hui Hu, Chin‐Chen Chang, et al.. (2018). Risk of sepsis in patients with primary aldosteronism. Critical Care. 22(1). 313–313. 10 indexed citations
18.
Chan, Chieh‐Kai, Tai‐Shuan Lai, Ping-Min Chen, et al.. (2017). Early initiation of immunosuppressive treatment in membranous nephropathy patients. Journal of the Formosan Medical Association. 116(4). 266–275. 3 indexed citations
19.
Chen, Ping-Min, Chieh‐Kai Chan, Wen‐Chih Chiang, et al.. (2015). Membranous nephropathy: A review on the pathogenesis, diagnosis, and treatment. Journal of the Formosan Medical Association. 114(2). 102–111. 93 indexed citations
20.
Huang, Yu‐Shan, Chieh‐Kai Chan, Mao‐Song Tsai, et al.. (2015). Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients. Journal of Microbiology Immunology and Infection. 50(5). 595–603. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026